243 related articles for article (PubMed ID: 23510032)
1. Serum levels and renal deposition of C1q complement component and its antibodies reflect disease activity of lupus nephritis.
Tan Y; Song D; Wu LH; Yu F; Zhao MH
BMC Nephrol; 2013 Mar; 14():63. PubMed ID: 23510032
[TBL] [Abstract][Full Text] [Related]
2. Combination of anti-C1q and anti-dsDNA antibodies is associated with higher renal disease activity and predicts renal prognosis of patients with lupus nephritis.
Yang XW; Tan Y; Yu F; Zhao MH
Nephrol Dial Transplant; 2012 Sep; 27(9):3552-9. PubMed ID: 22700716
[TBL] [Abstract][Full Text] [Related]
3. High prevalence of anti-C1q antibodies in biopsy-proven active lupus nephritis.
Trendelenburg M; Lopez-Trascasa M; Potlukova E; Moll S; Regenass S; Frémeaux-Bacchi V; Martinez-Ara J; Jancova E; Picazo ML; Honsova E; Tesar V; Sadallah S; Schifferli J
Nephrol Dial Transplant; 2006 Nov; 21(11):3115-21. PubMed ID: 16877491
[TBL] [Abstract][Full Text] [Related]
4. Correlation between the renal C1q deposition and serum anti-C1q antibody: a potential role of anti-C1q antibody in lupus nephritis.
Chen PC; Wang CR; Liu MF; Chen FF; Liang CC
Asian Pac J Allergy Immunol; 2002 Dec; 20(4):223-7. PubMed ID: 12744622
[TBL] [Abstract][Full Text] [Related]
5. Nonrenal and renal activity of systemic lupus erythematosus: a comparison of two anti-C1q and five anti-dsDNA assays and complement C3 and C4.
Julkunen H; Ekblom-Kullberg S; Miettinen A
Rheumatol Int; 2012 Aug; 32(8):2445-51. PubMed ID: 21706294
[TBL] [Abstract][Full Text] [Related]
6. C-reactive protein, immunoglobulin G and complement co-localize in renal immune deposits of proliferative lupus nephritis.
Sjöwall C; Olin AI; Skogh T; Wetterö J; Mörgelin M; Nived O; Sturfelt G; Bengtsson AA
Autoimmunity; 2013 May; 46(3):205-14. PubMed ID: 23331132
[TBL] [Abstract][Full Text] [Related]
7. Complement 1q (C1q) antibodies levels in sera of Egyptian patients with lupus nephritis.
Elshweikh SA; Elkhouly RM; Shaalan MM; Shorbagy SH
Egypt J Immunol; 2014; 21(2):49-59. PubMed ID: 25812352
[TBL] [Abstract][Full Text] [Related]
8. [The roles of complement 1q and anti-C1q autoantibodies in pathogenesis of lupus nephritis].
Zhang FC; Zhou B; Dong Y
Zhonghua Yi Xue Za Zhi; 2005 Apr; 85(14):955-9. PubMed ID: 16061001
[TBL] [Abstract][Full Text] [Related]
9. Anti-C1q antibodies in lupus nephritis and their correlation with the disease activity.
Emad G; Al-Barshomy SM
Saudi J Kidney Dis Transpl; 2020; 31(2):342-352. PubMed ID: 32394906
[TBL] [Abstract][Full Text] [Related]
10. Anti-C1q antibodies in nephritis: correlation between titres and renal disease activity and positive predictive value in systemic lupus erythematosus.
Marto N; Bertolaccini ML; Calabuig E; Hughes GR; Khamashta MA
Ann Rheum Dis; 2005 Mar; 64(3):444-8. PubMed ID: 15286009
[TBL] [Abstract][Full Text] [Related]
11. Detection of anti-C1q antibodies and anti-C1q globular head domain antibodies in sera from Chinese patients with lupus nephritis.
Tan Y; Zhou W; Yu F; Fang Q; Yang HZ; Zhao MH
Mol Immunol; 2009 Jul; 46(11-12):2178-82. PubMed ID: 19481805
[TBL] [Abstract][Full Text] [Related]
12. Significance of Anti-C1q Antibodies in Patients with Systemic Lupus Erythematosus as A Marker of Disease Activity and Lupus Nephritis.
Soliman AF; Egailla SE; Abdel-Gawad ER; Mansour AI; ElKhouly TH; Mahgoub MY
Egypt J Immunol; 2016 Jan; 23(1):107-116. PubMed ID: 28502158
[TBL] [Abstract][Full Text] [Related]
13. Serum levels of autoantibodies against C-reactive protein correlate with renal disease activity and response to therapy in lupus nephritis.
Sjöwall C; Zickert A; Skogh T; Wetterö J; Gunnarsson I
Arthritis Res Ther; 2009; 11(6):R188. PubMed ID: 20003354
[TBL] [Abstract][Full Text] [Related]
14. Association between anti-C1q antibodies and glomerular tuft necrosis in lupus nephritis.
Jourde-Chiche N; Daniel L; Chiche L; Burtey S; Mancini J; Jego S; San Marco M; Bardin N
Clin Nephrol; 2012 Mar; 77(3):211-8. PubMed ID: 22377252
[TBL] [Abstract][Full Text] [Related]
15. Serum A08 C1q antibodies are associated with disease activity and prognosis in Chinese patients with lupus nephritis.
Pang Y; Tan Y; Li Y; Zhang J; Guo Y; Guo Z; Zhang C; Yu F; Zhao MH
Kidney Int; 2016 Dec; 90(6):1357-1367. PubMed ID: 27745701
[TBL] [Abstract][Full Text] [Related]
16. Anti-C1q antibodies and antiendothelial cell antibodies in systemic lupus erythematosus - relationship with disease activity and renal involvement.
Oelzner P; Deliyska B; Fünfstück R; Hein G; Herrmann D; Stein G
Clin Rheumatol; 2003 Oct; 22(4-5):271-8. PubMed ID: 14576989
[TBL] [Abstract][Full Text] [Related]
17. Anti-C1q autoantibodies in lupus nephritis: prevalence and clinical significance.
Sinico RA; Radice A; Ikehata M; Giammarresi G; Corace C; Arrigo G; Bollini B; Li Vecchi M
Ann N Y Acad Sci; 2005 Jun; 1050():193-200. PubMed ID: 16014534
[TBL] [Abstract][Full Text] [Related]
18. Anti-C1q autoantibodies from active lupus nephritis patients could inhibit the clearance of apoptotic cells and complement classical pathway activation mediated by C1q in vitro.
Pang Y; Yang XW; Song Y; Yu F; Zhao MH
Immunobiology; 2014 Dec; 219(12):980-9. PubMed ID: 25092568
[TBL] [Abstract][Full Text] [Related]
19. Anti-C1q antibodies antedate patent active glomerulonephritis in patients with systemic lupus erythematosus.
Meyer OC; Nicaise-Roland P; Cadoudal N; Grootenboer-Mignot S; Palazzo E; Hayem G; Dieudé P; Chollet-Martin S
Arthritis Res Ther; 2009; 11(3):R87. PubMed ID: 19515233
[TBL] [Abstract][Full Text] [Related]
20. Anti-C1q antibodies have higher correlation with flares of lupus nephritis than other serum markers.
Akhter E; Burlingame RW; Seaman AL; Magder L; Petri M
Lupus; 2011 Oct; 20(12):1267-74. PubMed ID: 21813587
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
